Antipsychotic polypharmacy: A Japanese survey of prescribers' attitudes and rationales
- 18 April 2013
- journal article
- Published by Elsevier BV in Psychiatry Research
- Vol. 209 (3), 406-411
- https://doi.org/10.1016/j.psychres.2013.03.014
Abstract
No abstract availableFunding Information
- National Institute of Mental Health
- Astellas Foundation for Research on Metabolic Disorders
This publication has 42 references indexed in Scilit:
- Antipsychotic Polypharmacy: A Comprehensive Evaluation of Relevant Correlates of a Long-Standing Clinical PracticePsychiatric Clinics of North America, 2012
- Prevalence and correlates of antipsychotic polypharmacy: A systematic review and meta-regression of global and regional trends from the 1970s to 2009Schizophrenia Research, 2012
- Critical review of antipsychotic polypharmacy in the treatment of schizophreniaInternational Journal of Neuropsychopharmacology, 2012
- Antipsychotic polypharmacy: A survey study of prescriber attitudes, knowledge and behaviorSchizophrenia Research, 2011
- Association of antipsychotic polypharmacy with health service cost: a register-based cost analysisThe European Journal of Health Economics, 2011
- Evaluation of a multifaceted intervention to limit excessive antipsychotic co‐prescribing in schizophrenia out‐patientsActa Psychiatrica Scandinavica, 2010
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary StatementsSchizophrenia Bulletin, 2009
- Antipsychotic Combinations vs Monotherapy in Schizophrenia: A Meta-analysis of Randomized Controlled TrialsSchizophrenia Bulletin, 2008
- Simultaneous prescribing of atypical antipsychotics, conventional antipsychotics and anticholinergics—a European studyPharmacy World & Science, 2007
- Does antipsychotic polypharmacy increase the risk for metabolic syndrome?Schizophrenia Research, 2007